CEO statement
“The letter of intent with Recardio Inc. makes strong business sense and improves the opportunities to advance our program in acute myocardial infarction to the next clinical phase.”
Peter Selin, CEO Kancera
“The letter of intent with Recardio Inc. makes strong business sense and improves the opportunities to advance our program in acute myocardial infarction to the next clinical phase.”